| ID: 130001957 | ATAC-STARR-seq lymphoblastoid silent region 19986 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85425260..85425359) | | |
| ID: 130001956 | ATAC-STARR-seq lymphoblastoid active region 28512 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85420974..85421023) | | |
| ID: 127815057 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr9:88081573-88082402 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85466658..85467487) | | |
| ID: 127815056 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr9:88073054-88073928 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85458139..85459013) | | |
| ID: 127815055 | NANOG hESC enhancer GRCh37_chr9:87836950-87837451 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85222035..85222536) | | |
| ID: 126860664 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr9:88029701-88030900 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85414786..85415985) | | |
| ID: 126860663 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr9:87872518-87873717 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85257212..85258814) | | |
| ID: 124902322 | uncharacterized LOC124902322 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85290389..85291750) | | |
| ID: 107987089 | uncharacterized LOC107987089 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85370910..85374408, complement) | | |
| ID: 105376121 | uncharacterized LOC105376121 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85402168..85444382, complement) | | |
| ID: 105376119 | uncharacterized LOC105376119 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85269699..85289474, complement) | | |
| ID: 102724605 | UBE2V1 pseudogene 10 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85159682..85159950) | | |
| ID: 101927603 | uncharacterized LOC101927603 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85534067..85536004, complement) | | |
| ID: 553118 | serine/threonine kinase 33 pseudogene 1 [Homo sapiens (human)] | Chromosome 9, NC_000009.12 (85492579..85494094) | STK33P, STK33ps | |